ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery. Founded by Michel Detheux in 2011, ITeos Therapeutics is backed by investors that include 6 Dimensions Capital, Boxer Capital, curative ventures, Fund+, HBM Partners, Invus, Janus Henderson Investors, MPM Capital, RA Capital Management, RTW Investments LLC, S.R.I.W., SFPI-FPIM, and Vives Fund and is headquartered in Gosselies.